Skip to content
Screener

ADMA Biologics ADMA Plasma Collection Centers — Total Assets

Other segment segments

ADMA Bio Manufacturing
$453.54M+23.2%

Similar metrics at other companies

American Tower logo
AMTData Centers — Total Assets
$10.79B+0.8%
Galaxy Digital logo
GLXYData Centers — Total Assets
$2.54B+230%
AptarGroup logo
ATRPharma — Total Assets
$2.28B+11.0%
Icahn Enterprises logo
IEPPharma — Total Assets
$216M-14.6%
Modine Manufacturing logo
MODData Center — Total Assets
$513M
DXP Enterprises logo
DXPEService Center — Total Assets
$848.86M+7.0%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.25B-49.1%
Enterprise value$2.32B-46.6%
P/E13.3×-7.9×
P/S4.4×-4.9×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001140361-26-031445
(in thousands)ADMA Bio ManufacturingPlasma Collection CentersTotal
Other income (expense), net(20)150130
Income (loss) before taxes64,010(707)63,303
Expenditures for additions to long-lived assets2,256-2,256
Total assets453,53821,864475,402
Reconciliation of revenues:
Segment revenue$124,360
License revenue35
Consolidated revenues$124,395

Item 1. Financial Statements.

FAQ

What is ADMA Biologics's plasma collection centers — total assets?
ADMA Biologics (ADMA) reported plasma collection centers — total assets of $21.86M in Q2 2026.
How has ADMA Biologics's plasma collection centers — total assets changed year-over-year?
ADMA Biologics's plasma collection centers — total assets decreased by 25.0% year-over-year, from $29.16M to $21.86M.
What is the long-term trend for ADMA Biologics's plasma collection centers — total assets?
Over 4 years (2021 to 2025), ADMA Biologics's plasma collection centers — total assets has grown at a 7.2% compound annual growth rate (CAGR), from $84.95M to $112.33M.
What does plasma collection centers — total assets mean?
This metric reflects the total book value of assets directly attributable to the plasma collection segment, including property, plant, equipment, and intangible assets. It provides a measure of the capital base required to maintain and operate the collection network. Tracking this asset base helps evaluate the efficiency of capital utilization within the segment.

Ask your AI about ADMA Biologics's plasma collection centers — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude